104 related articles for article (PubMed ID: 2558543)
1. Dideoxycytidine metabolism in wild type and mutant CEM cells deficient in nucleoside transport or deoxycytidine kinase.
Ullman B
Adv Exp Med Biol; 1989; 253B():415-20. PubMed ID: 2558543
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of 2',3'-dideoxycytidine incorporation into cultured human T lymphoblasts.
Ullman B; Coons T; Rockwell S; McCartan K
J Biol Chem; 1988 Sep; 263(25):12391-6. PubMed ID: 2842332
[TBL] [Abstract][Full Text] [Related]
3. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
Törnevik Y; Eriksson S
Mol Pharmacol; 1990 Aug; 38(2):237-43. PubMed ID: 2166904
[TBL] [Abstract][Full Text] [Related]
4. Substrate specificity of human deoxycytidine kinase toward antiviral 2',3'-dideoxynucleoside analogs.
Kierdaszuk B; Bohman C; Ullman B; Eriksson S
Biochem Pharmacol; 1992 Jan; 43(2):197-206. PubMed ID: 1739408
[TBL] [Abstract][Full Text] [Related]
5. 2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line.
Magnani M; Brandi G; Casabianca A; Fraternale A; Schiavano GF; Rossi L; Chiarantini L
Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):115-23. PubMed ID: 7492300
[TBL] [Abstract][Full Text] [Related]
6. The role of cytoplasmic deoxycytidine kinase in the mitochondrial effects of the anti-human immunodeficiency virus compound, 2',3'-dideoxycytidine.
Chen CH; Cheng YC
J Biol Chem; 1992 Feb; 267(5):2856-9. PubMed ID: 1310674
[TBL] [Abstract][Full Text] [Related]
7. Cross-resistance to anti-HIV nucleoside analogs in multidrug-resistant human cells.
Yusa K; Oh-hara T; Yamazaki A; Tsukahara S; Satoh W; Tsuruo T
Biochem Biophys Res Commun; 1990 Jun; 169(3):986-90. PubMed ID: 2163639
[TBL] [Abstract][Full Text] [Related]
8. S-adenosylhomocysteine hydrolase inactivation and purine toxicity in cultured human T- and B-lymphoblasts.
Young GJ; Hallam LJ; Jack I; Van Der Weyden MB
J Lab Clin Med; 1984 Jul; 104(1):86-95. PubMed ID: 6330251
[TBL] [Abstract][Full Text] [Related]
9. Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides.
Van Draanen NA; Tisdale M; Parry NR; Jansen R; Dornsife RE; Tuttle JV; Averett DR; Koszalka GW
Antimicrob Agents Chemother; 1994 Apr; 38(4):868-71. PubMed ID: 7518218
[TBL] [Abstract][Full Text] [Related]
10. Increased mitochondrial DNA copy-number in CEM cells resistant to delayed toxicity of 2',3'-dideoxycytidine.
Bjerke M; Franco M; Johansson M; Balzarini J; Karlsson A
Biochem Pharmacol; 2008 Mar; 75(6):1313-21. PubMed ID: 18206854
[TBL] [Abstract][Full Text] [Related]
11. Nucleoside transport and cytosine arabinoside (araC) metabolism in human T lymphoblasts resistant to araC, thymidine and 6-methylmercaptopurine riboside.
Young I; Young GJ; Wiley JS; van der Weyden MB
Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1077-82. PubMed ID: 3877635
[TBL] [Abstract][Full Text] [Related]
12. ddC- and 3TC-bis(SATE) monophosphate prodrugs overcome cellular resistance mechanisms to HIV-1 associated with cytidine kinase deficiency.
Gröschel B; Himmel N; Cinatl J; Périgaud C; Gosselin G; Imbach JL; Doerr HW; Cinatl J
Nucleosides Nucleotides; 1999; 18(4-5):921-6. PubMed ID: 10432710
[TBL] [Abstract][Full Text] [Related]
13. Role of the nucleoside transport function in the transport and salvage of purine nucleobases.
Aronow B; Ullman B
J Biol Chem; 1986 Feb; 261(5):2014-9. PubMed ID: 3484740
[TBL] [Abstract][Full Text] [Related]
14. Metabolic pathways for the activation of the antiviral agent 2',3'-dideoxyguanosine in human lymphoid cells.
Bondoc LL; Ahluwalia G; Cooney DA; Hartman NR; Johns DG; Fridland A
Mol Pharmacol; 1992 Sep; 42(3):525-30. PubMed ID: 1328848
[TBL] [Abstract][Full Text] [Related]
15. Incomplete nucleoside transport deficiency with increased hypoxanthine transport capability in mutant T-lymphoblastoid cells.
Aronow B; Hollingsworth P; Patrick J; Ullman B
Mol Cell Biol; 1986 Apr; 6(4):1296-303. PubMed ID: 3491289
[TBL] [Abstract][Full Text] [Related]
16. Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AML.
Liyanage SU; Hurren R; Voisin V; Bridon G; Wang X; Xu C; MacLean N; Siriwardena TP; Gronda M; Yehudai D; Sriskanthadevan S; Avizonis D; Shamas-Din A; Minden MD; Bader GD; Laposa R; Schimmer AD
Blood; 2017 May; 129(19):2657-2666. PubMed ID: 28283480
[TBL] [Abstract][Full Text] [Related]
17. Thymidine incorporation in nucleoside transport-deficient lymphoma cells.
Aronow B; Ullman B
J Biol Chem; 1985 Dec; 260(30):16274-8. PubMed ID: 3877729
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
Bhalla K; Nayak R; Grant S
Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869
[TBL] [Abstract][Full Text] [Related]
19. Alterations of mitochondrial DNA in CEM cells selected for resistance toward ddC toxicity.
Bjerke M; Franco M; Johansson M; Balzarini J; Karlsson A
Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):987-90. PubMed ID: 17065051
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the metabolism of beta-L-(-)-2',3'-dideoxy-3'-thiacytidine by thymidine, fludarabine, and nitrobenzylthioinosine.
Rahn JJ; Kieller DM; Tyrrell DL; Gati WP
Antimicrob Agents Chemother; 1997 May; 41(5):918-23. PubMed ID: 9145844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
